Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-025572

Chief Executive Officer sold 3,000 shares at $58.62 ($175,860)

  • Chief Executive Officer acquired 3,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schenkein David P Chief Executive Officer 2017-04-03 Option exercise +3,000 $0.30 $908 3,000 D: show line 1 in the form
Schenkein David P Chief Executive Officer 2017-04-03 Sale −3,000 $58.62 $175,860 0 D: show line 2 in the form
Open-market sales · 3,000 sh · avg $58.62 · $175,860

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schenkein David P Chief Executive Officer 2017-04-03 Option exercise · Stock option (right to buy) −3,000 195,656 D: show line 3 in the form
Loading xslF345X03/doc4.xml…